Breaking News Instant updates and real-time market news.

LXRX

Lexicon

$2.01

0.59 (41.55%)

08:04
09/11/19
09/11
08:04
09/11/19
08:04

Lexicon upgraded to Buy from Hold at Gabelli

LXRX Lexicon
$2.01

0.59 (41.55%)

07/29/19
STFL
07/29/19
DOWNGRADE
Target $4
STFL
Hold
Lexicon downgraded to Hold from Buy at Stifel
Stifel analyst Stephen Willey downgraded Lexicon Pharmaceuticals to Hold from Buy and cut his price target for the shares to $4 from $10. Sanofi's (SNY) planned sotagliflozin exodus and Phase 3 trials of Zynquista in adults living with type 2 diabetes clouds the company's visibility, Willey tells investors in a research note. Sanofi's decision to terminate the sotagliflozin licensing and collaborative agreement creates "even more uncertainty" for a story which, following FDA's Complete Response Letter for a potential Type-1 diabetes label, "already lacked meaningful visibility," says the analyst.
07/30/19
SBSH
07/30/19
NO CHANGE
Target $3
SBSH
Buy
Citi cuts Lexicon target to $3 from $15, still sees value in sotagliflozin
Citi analyst Yigal Nochomovitz lowered his price target for Lexicon Pharmaceuticals (LXRX) to $3 from $15 while keeping a Buy rating on the shares. The analyst believes Sanofi's (SNY) decision to terminate the partnership reflects to a greater extent Sanofi's prioritization of the internal pipeline and renewed focus on core areas versus specific liabilities regarding sotagliflozin. He still sees see some value in sotagliflozin and thinks shares of Lexicon are worth $3, well above yesterday's closing price of $1.69.
08/01/19
WEDB
08/01/19
NO CHANGE
Target $17
WEDB
Outperform
Lexicon price target lowered to $17 from $35 at Wedbush
Wedbush analyst Liana Moussatos lowered her price target for Lexicon (LXRX) to $17 from $35 to reflect a reduction in Zynquist sales projections. On July 26, partner Sanofi (SNY) announced the intent to terminate the diabetes partnership for Zynquista, which Lexicon indicated was due to not achieving statistical significance for the primary endpoint of reducing placebo-adjusted HbA1c in T2D patients with stage 3b/4 CKD, she contends, adding that Lexicon commented that there were strong trends favoring Zynquista in these patients and is disputing the termination. Moussatos reiterates an Outperform rating on Lexicon's shares.
09/11/19
SBSH
09/11/19
NO CHANGE
Target $3
SBSH
Buy
Lexicon settlement with Sanofi removes overhang, says Citi
Citi analyst Yigal Nochomovitz believes Lexicon Pharmaceuticals' (LXRX) settlement with Sanofi (SNY) removes an overhang and that the company's cash runway "may increase modestly." However, the funds are largely already spoken for with respect to continued funding of the core Phase 3 trials in n type 2 diabetes and the outcomes trials, Nochomovitz tells investors in a research note. The analyst keeps a Buy rating on Lexicon shares with a $3 price target.

TODAY'S FREE FLY STORIES

CAG

Conagra Brands

$29.95

0.3 (1.01%)

14:55
09/20/19
09/20
14:55
09/20/19
14:55
Options
ConAgra put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 01

    Oct

14:50
09/20/19
09/20
14:50
09/20/19
14:50
General news
Fed's Kaplan said he backed the Fed's rate cuts in September and July »

Fed's Kaplan said he…

FB

Facebook

$189.71

-0.44 (-0.23%)

14:48
09/20/19
09/20
14:48
09/20/19
14:48
Hot Stocks
Facebook says has suspended 'tens of thousands' of apps over data use »

In a blog post, Facebook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

SKT

Tanger Factory

$15.90

0.13 (0.82%)

14:35
09/20/19
09/20
14:35
09/20/19
14:35
Options
Tanger Factory put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:35
09/20/19
09/20
14:35
09/20/19
14:35
General news
Action Economics Survey results: »

Action Economics Survey…

USAT

USA Technologies

$7.43

-0.22 (-2.88%)

14:31
09/20/19
09/20
14:31
09/20/19
14:31
Hot Stocks
Breaking Hot Stocks news story on USA Technologies »

USA Technologies trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAT

USA Technologies

$7.43

-0.22 (-2.88%)

14:28
09/20/19
09/20
14:28
09/20/19
14:28
Hot Stocks
USA Technologies says unlikely to meet Nasdaq deadline for filing compliance »

USA Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAT

USA Technologies

$7.43

-0.22 (-2.88%)

14:26
09/20/19
09/20
14:26
09/20/19
14:26
Hot Stocks
Breaking Hot Stocks news story on USA Technologies »

USA Technologies trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FISV

Fiserv

$104.82

-0.03 (-0.03%)

14:25
09/20/19
09/20
14:25
09/20/19
14:25
Options
Fiserv call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 27

    Oct

TD

Toronto-Dominion

$57.97

0.4 (0.69%)

, DB

Deutsche Bank

$8.02

-0.055 (-0.68%)

14:24
09/20/19
09/20
14:24
09/20/19
14:24
Hot Stocks
TD accepted Epstein accounts after Deutsche cut ties, Bloomberg says »

Canadian lender…

TD

Toronto-Dominion

$57.97

0.4 (0.69%)

DB

Deutsche Bank

$8.02

-0.055 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

IVV

iShares Core S&P 500

$301.93

-0.845 (-0.28%)

, SPY

SPDR S&P 500 ETF Trust

$298.77

-0.906381 (-0.30%)

14:22
09/20/19
09/20
14:22
09/20/19
14:22
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

ETF fund flows to the top…

IVV

iShares Core S&P 500

$301.93

-0.845 (-0.28%)

SPY

SPDR S&P 500 ETF Trust

$298.77

-0.906381 (-0.30%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$87.41

0.05 (0.06%)

IEF

iShares 7-10 Year Treasury Bond ETF

$111.69

0.335 (0.30%)

ITE

SPDR Bloomberg Barclays Intermediate Term Treasury ETF

$62.19

0.065 (0.10%)

SPTL

SPDR Portfolio Long Term Treasury ETF

$40.45

0.12 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
09/20/19
09/20
14:17
09/20/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
09/20/19
09/20
14:16
09/20/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDD

Pinduoduo

$33.65

-0.98 (-2.83%)

14:15
09/20/19
09/20
14:15
09/20/19
14:15
Options
Pinduoduo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$4.00

0.3347 (9.13%)

14:11
09/20/19
09/20
14:11
09/20/19
14:11
Periodicals
Fitbit deciding whether to explore sale, Reuters says »

Fitbit (FIT) has held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$3.69

0.025 (0.68%)

14:07
09/20/19
09/20
14:07
09/20/19
14:07
Hot Stocks
Fitbit rises after report of hiring bank to consider sale »

Shares of Fitbit are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$3.73

0.06 (1.64%)

14:03
09/20/19
09/20
14:03
09/20/19
14:03
Periodicals
Breaking Periodicals news story on Fitbit »

Fitbit in talks with bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$122.80

-5.865 (-4.56%)

13:55
09/20/19
09/20
13:55
09/20/19
13:55
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DELL

Dell Technologies

$52.26

-0.8 (-1.51%)

13:53
09/20/19
09/20
13:53
09/20/19
13:53
Conference/Events
Dell Technologies to hold a business news update meeting »

CFO Sweet, along with SVP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Nov

FTR

Frontier Communications

$1.00

-0.0006 (-0.06%)

13:43
09/20/19
09/20
13:43
09/20/19
13:43
Periodicals
Frontier Communications prepares for debt restructuring talks, WSJ reports »

Frontier Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:40
09/20/19
09/20
13:40
09/20/19
13:40
General news
U.S. equity markets »

U.S. equity markets were…

BTU

Peabody Energy

$15.47

-1.56 (-9.16%)

, ARCH

Arch Coal

$71.00

-5.37 (-7.03%)

13:39
09/20/19
09/20
13:39
09/20/19
13:39
Hot Stocks
Peabody Energy confirms commitment to pending PRB/Colorado joint venture »

Peabody (BTU) confirmed…

BTU

Peabody Energy

$15.47

-1.56 (-9.16%)

ARCH

Arch Coal

$71.00

-5.37 (-7.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

SPY

SPDR S&P 500 ETF Trust

$298.09

-1.586381 (-0.53%)

, SPX

S&P 500

$0.00

(0.00%)

13:34
09/20/19
09/20
13:34
09/20/19
13:34
Periodicals
Chinese delgation cancels farm trip to Montana, Reuters reports »

Chinese officials that…

SPY

SPDR S&P 500 ETF Trust

$298.09

-1.586381 (-0.53%)

SPX

S&P 500

$0.00

(0.00%)

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

NDX

Nasdaq 100 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RACE

Ferrari

$151.80

-1.95 (-1.27%)

13:30
09/20/19
09/20
13:30
09/20/19
13:30
Options
Trader trims risk by legging out of iron condor in Ferrari »

Trader trims risk by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$29.05

-0.01 (-0.03%)

13:25
09/20/19
09/20
13:25
09/20/19
13:25
Options
MGM Resorts call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.